Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -26.139% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) Cc1ccc(C(=O)NC(C)c2ccc3c(c2)OCO3)s1
b) CCOC(=O)c1cccc(-[n+]2c(-c3ccccc3)cc(-c3ccccc3)cc2-c2ccccc2)c1.[O-][Cl+3]([O-])([O-])[O-]
c) CCN(CC(=O)Nc1cccc(C#N)c1)CC(=O)Nc1cccc(OC)c1
d) Clc1ccc2nc(-c3ccccc3)c(CN3CCOCC3)n2c1
Answer: d. Clc1ccc2nc(-c3ccccc3)c(CN3CCOCC3)n2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc2nc(-c3ccccc3)c(CN3CCOCC3)n2c1
Clc1ccc2nc(-c3ccccc3)c(CN3CCOCC3)n2c1
4-[(6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine